BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23412795)

  • 1. Comparative genomic hybridization of Wilms' tumor.
    Rassekh SR; Rajcan-Separovic E
    Methods Mol Biol; 2013; 973():249-65. PubMed ID: 23412795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
    Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
    Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
    Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
    Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
    Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.
    Hing S; Lu YJ; Summersgill B; King-Underwood L; Nicholson J; Grundy P; Grundy R; Gessler M; Shipley J; Pritchard-Jones K
    Am J Pathol; 2001 Feb; 158(2):393-8. PubMed ID: 11159177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome analysis of 31 Wilms' tumors.
    Sheng WW; Soukup S; Bove K; Gotwals B; Lampkin B
    Cancer Res; 1990 May; 50(9):2786-93. PubMed ID: 2158398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
    Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
    Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
    Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
    Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.
    Benetkiewicz M; Díaz de Ståhl T; Gördör A; Pfeifer S; Wittmann S; Gessler M; Dumanski JP
    Int J Cancer; 2006 Aug; 119(3):571-8. PubMed ID: 16496407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
    Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
    Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytogenetic study of Wilms' tumor.
    Slater RM; de Kraker J; Voûte PA; Delemarre JF
    Cancer Genet Cytogenet; 1985 Jan; 14(1-2):95-109. PubMed ID: 2981155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of array comparative genomic hybridization in cytogenetic analysis.
    Singh RR; Cheung KJ; Horsman DE
    Methods Mol Biol; 2011; 730():219-34. PubMed ID: 21431645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K; Hastie ND
    Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization and its application to Wilms' tumorigenesis.
    Getman ME; Houseal TW; Miller GA; Grundy PE; Cowell JK; Landes GM
    Cytogenet Cell Genet; 1998; 82(3-4):284-90. PubMed ID: 9858837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.
    Zin R; Pham K; Ashleigh M; Ravine D; Waring P; Charles A
    Cancer Genet; 2012 Mar; 205(3):80-93. PubMed ID: 22469507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.